| H-1202 | C25H37N5O8 | 535.60 | 137372-00-0 | Ac-Thr-Leu-Asn-Phe-OH | |
| H-1203 | C36H49N7O11 | 755.83 | 150626-30-5 | Ac-Thr-Val-Ser-Phe-Asn-Phe-OH | |
| H-1204 | Anthranilyl-HIV Protease Substrate | C43H65N13O11 | 940.07 | 133233-38-2 | Abz-Thr-Ile-Nle-p-nitro-Phe-Gln-Arg-NH2 |
| H-1205 | Anthranilyl-HIV Protease Substrate III | C65H100N20O17 | 1433.63 | 138668-80-1 | Abz-His-Lys-Ala-Arg-Val-Leu-p-nitro-Phe-Glu-Ala-Nle-Ser-NH2 |
| H-1206 | Anthranilyl-HIV Protease Substrate IV | C56H88N16O14 | 1209.41 | 141223-69-0 | Abz-Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
| H-1207 | Anthranilyl-HIV Protease Substrate V | C50H76N14O13 | 1081.24 | 210644-48-7 | Abz-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
| H-1208 | Anthranilyl-HIV Protease Substrate VI | C47H71N13O12 | 1010.16 | 210644-49-8 | Abz-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
| H-1209 | C93H156N26O19S2 | 2006.56 | 118720-30-2 | H-Lys-Arg-Trp-Ile-Ile-Leu-Gly-Leu-Asn-Lys-Ile-Val-Arg-Met-Tyr-Cys-OH | |
| H-1210 | (Cys(Bzl)84)-CD4 (81-92) | C69H102N14O26S | 1575.71 | 123380-68-7 | H-Thr-Tyr-Ile-Cys(Bzl)-Glu-Val-Glu-Asp-Gln-Lys-Glu-Glu-OH |
| H-1211 | (Cys(Bzl)84,Glu(OBzl)85)-CD4 (81-92) | C76H108N14O26S | 1665.84 | H-Thr-Tyr-Ile-Cys(Bzl)-Glu(OBzl)-Val-Glu-Asp-Gln-Lys-Glu-Glu-OH | |
| H-1212 | CDR-H3/C2 | C98H120N16O34S2 | 2130.25 | H-Cys-Asp-Leu-Ile-Tyr-Tyr-Asp-Tyr-Glu-Glu-Asp-Tyr-Tyr-Phe-Asp-Cys-OH (Disulfide bond) |
|
| H-1213 | C73H97N17O18S | 1532.74 | 127134-13-8 | DABCYL-γ-Abu-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-EDANS Trifluoroacetate salt |
|
| H-1214 | C46H55N11O7S | 906.08 | 172546-75-7 | H-His-Cys-Lys-Phe-Trp-Trp-OH | |
| H-1215 | HIV (gp120) Fragment (254-274) | C95H162N28O30S | 2208.57 | 113944-46-0 | H-Cys-Thr-His-Gly-Ile-Arg-Pro-Val-Val-Ser-Thr-Gln-Leu-Leu-Leu-Asn-Gly-Ser-Leu-Ala-Glu-OH |
| H-1216 | HIV (gp120) Fragment (308-331) | C114H199N41O31 | 2640.09 | H-Asn-Asn-Thr-Arg-Lys-Ser-Ile-Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys-Ile-Gly-OH | |
| H-1217 | HIV (gp120) Fragment (318-327) I-10, P18IIIB I10 |
C48H80N16O12 | 1073.26 | H-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-OH | |
| H-1218 | HIV (gp120) Fragment (421-438) | C99H148N24O25S2 | 2138.54 | 129318-38-3 | H-Lys-Gln-Phe-Ile-Asn-Met-Trp-Gln-Glu-Val-Gly-Lys-Ala-Met-Tyr-Ala-Pro-Pro-OH Trifluoroacetate salt |
| H-1219 | HIV (gp120) Antigenic Peptide | C117H211N41O31S | 2720.29 | 198636-94-1 | H-Cys-Gly-Lys-Ile-Glu-Pro-Leu-Gly-Val-Ala-Pro-Thr-Lys-Ala-Lys-Arg-Arg-Val-Val-Gln-Arg-Glu-Lys-Arg-OH Trifluoroacetate salt |
| H-1220 | HIV (gp41) Fragment | C21H38N6O7 | 486.57 | 129426-47-7 | H-Ala-Val-Gly-Ile-Gly-Ala-OH |
| H-1221 | HIV (gp41) Antigenic Peptide 5 | C184H282N56O53S2 | 4190.74 | H-Arg-Val-Thr-Ala-Ile-Glu-Lys-Tyr-Leu-Gln-Asp-Gln-Ala-Arg-Leu-Asn-Ser-Trp-Gly-Cys-Ala-Phe-Arg-Gln-Val-Cys-His-Thr-Thr-Val-Pro-Trp-Val-Asn-Asp-Ser-NH2 (Disulfide bond) | |
| H-1222 | HIV Protease Substrate II | C72H109N15O25 | 1584.74 | 120944-74-3 | Suc-Lys-Asp-Ser-Ser-Leu-Tyr-Pro-Ala-Leu-Thr-Phe-Asp-Lys-OH |
| H-1223 | HIV Protease Substrate III | C58H95N19O16 | 1314.51 | 138608-20-5 | H-His-Lys-Ala-Arg-Val-Leu-p-nitro-Phe-Glu-Ala-Nle-Ser-NH2 |
| H-1224 | HIV Protease Substrate III-B (Native Sequence) | C51H90N18O14S | 1211.46 | H-His-Lys-Ala-Arg-Val-Leu-Ala-Glu-Ala-Met-Ser-NH2 | |
| H-1225 | HIV Protease Substrate IV | C49H83N15O13 | 1090.29 | 128340-47-6 | H-Lys-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 |
| H-1226 | HIV Protease Substrate V | C43H71N13O12 | 962.12 | H-Ala-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 | |
| H-1227 | HIV Protease Substrate VI | C40H66N12O11 | 891.04 | H-Arg-Val-Nle-p-nitro-Phe-Glu-Ala-Nle-NH2 | |
| H-1228 | HIV Protease Substrate VII | C52H81N15O14 | 1140.31 | H-Lys-Ala-Arg-Val-Tyr-p-nitro-Phe-Glu-Ala-Nle-NH2 | |
| H-1229 | HIV Protease Substrate VIII | C42H66N10O13 | 919.05 | H-Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-OH | |
| H-1230 | HIV-1 env Protein gp120 (278-292) (strains BH10, BH8, HXB2, HXB3, PV22), HIV-1 env Protein gp120 (283-297) (strain BRU), P18IIIB, HIV gp120 Fragment (315-329) | C73H126N26O18 | 1655.97 | 114991-28-5 | H-Arg-Ile-Gln-Arg-Gly-Pro-Gly-Arg-Ala-Phe-Val-Thr-Ile-Gly-Lys-OH |
| H-1231 | HIV-1 env Protein gp41 (1-23) amide (isolates BRU/JRCSF) | C95H155N27O26S | 2123.51 | 128631-86-7 | H-Ala-Val-Gly-Ile-Gly-Ala-Leu-Phe-Leu-Gly-Phe-Leu-Gly-Ala-Ala-Gly-Ser-Thr-Met-Gly-Ala-Arg-Ser-NH2 |
| H-1232 | HIV-1 gag Polyprotein (121-140) | C86H138N26O34 | 2080.20 | H-Asp-Thr-Gly-Ser-Ser-Ser-Lys-Val-Ser-Gln-Asn-Tyr-Pro-Ile-Val-Gln-Asn-Ala-Gln-Gly-OH | |
| H-1233 | HIV-1 gag Protein p17 (76-84) SL9 |
C44H72N10O15 | 981.11 | 147468-65-3 | H-Ser-Leu-Tyr-Asn-Thr-Val-Ala-Thr-Leu-OH Acetate salt |
| H-1234 | HIV-1 gag Protein p24 (65-73) (isolates MAL/U455) | C44H79N11O14S2 | 1050.31 | 334731-59-8 | H-Ala-Met-Gln-Met-Leu-Lys-Asp-Thr-Ile-OH Trifluoroacetate salt |
| H-1235 | HIV-1 gag Protein p24 (137-154) | C92H158N26O26S | 2076.49 | H-Gly-Leu-Asn-Lys-Ile-Val-Arg-Met-Tyr-Ser-Pro-Thr-Ser-Ile-Leu-Asp-Ile-Arg-OH | |
| H-1236 | HIV-1 gag Protein p24 (194-210) | C73H126N20O23S | 1683.99 | 141281-67-6 | H-Ala-Asn-Pro-Asp-Cys-Lys-Thr-Ile-Leu-Lys-Ala-Leu-Gly-Pro-Ala-Ala-Thr-OH |
| H-1237 | HIV-1 rev Protein (34-50) | C97H173N51O24 | 2437.77 | 141237-50-5 | H-Thr-Arg-Gln-Ala-Arg-Arg-Asn-Arg-Arg-Arg-Arg-Trp-Arg-Glu-Arg-Gln-Arg-OH |
| H-1238 | HIV-1 tat Protein (1-9) | C43H68N10O17S | 1029.14 | 200203-20-9 | H-Met-Asp-Pro-Val-Asp-Pro-Asn-Ile-Glu-OH |
| H-1239 | HIV-1 tat Protein (47-57) | C64H118N32O14 | 1559.85 | 191936-91-1 | H-Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH Trifluoroacetate salt |
| H-1240 | HIV-1 tat Protein (49-57) | C53H106N30O11 | 1339.62 | 123251-89-8 | H-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-OH Trifluoroacetate salt |
| H-1241 | HTLV-1 Tax (11-19), HTLV-1 X-Lor Protein (16-24) (strains ATK, Caribbean), HTLV-1 PX Protein (16-24) (strains ATK, Caribbean), X-Lor Protein (16-24) (Human T-Cell Leukemia Virus Type I) (strains ATK, Caribbean), PX Protein (16-24) (Human T-Cell Leukemia Virus Type I) (strains ATK, Caribbean), HTLV-1 Trans-Activating Transcriptional Regulatory Protein (16-24) (strains ATK, Caribbean) | C56H79N9O12 | 1070.30 | 141677-18-1 | H-Leu-Leu-Phe-Gly-Tyr-Pro-Val-Tyr-Val-OH |
| H-1242 | Asn-Ala-Intercellular Adhesion Molecule 1 (1-21) (human) Asn-Ala-ICAM 1 (1-21) (human) |
C99H173N29O32S | 2313.72 | 139227-42-2 | H-Asn-Ala-Gln-Thr-Ser-Val-Ser-Pro-Ser-Lys-Val-Ile-Leu-Pro-Arg-Gly-Gly-Ser-Val-Leu-Val-Thr-Cys-OH |
| H-1243 | C37H57N9O12 | 819.91 | 118071-31-1 | H-Ser-Gln-Asn-Tyr-Pro-Ile-Val-OH | |
| H-1244 | SIVmac251 (gp140) Fragment (171-190) [Cys] | C118H180N30O35S2 | 2643.04 | H-Lys-Phe-Thr-Met-Thr-Gly-Leu-Lys-Arg-Asp-Lys-Thr-Lys-Glu-Tyr-Asn-Glu-Thr-Trp-Tyr-Cys-OH | |
| H-1301 | Abz-Glu-Thr-Leu-Phe-Gln-Gly-Pro-Val-p-nitro-Phe-NH2 Trifluoroacetate salt |
C57H77N13O16 | 1200.32 | 396096-53-0 | Abz-Glu-Thr-Leu-Phe-Gln-Gly-Pro-Val-p-nitro-Phe-NH2 Trifluoroacetate salt |
| H-1302 | H-Arg-Lys-Gly-Asp-Ile-Lys-Ser-Tyr-pNA | C48H75N15O14 | 1086.22 | 204450-29-3 | H-Arg-Lys-Gly-Asp-Ile-Lys-Ser-Tyr-pNA |
| H-1303 | H-Glu-Ala-Leu-Phe-Gln-pNA | C34H46N8O10 | 726.79 | 198551-00-7 | H-Glu-Ala-Leu-Phe-Gln-pNA |
| H-1304 | H-Thr-Arg-Pro-Ile-Ile-Thr-Thr-m-nitro-Tyr-Gly-Pro-Ser-Asp-Lys(Abz)-Tyr-OH | C80H118N20O26 | 1775.94 | 213135-91-2 | H-Thr-Arg-Pro-Ile-Ile-Thr-Thr-Tyr(3-NO2)-Gly-Pro-Ser-Asp-Lys(Abz)-Tyr-OH |
| H-1401 | Humanin (human) | C119H204N34O32S2 | 2687.27 | 330936-69-1 | H-Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH |
| H-1402 | (Gly14)-Humanin (human) | C118H202N34O31S2 | 2657.25 | 330936-70-4 | H-Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala-OH |
| H-1403 | Colivelin | C119H206N32O35 | 2645.14 | 867021-83-8 | H-Ser-Ala-Leu-Leu-Arg-Ser-Ile-Pro-Ala-Pro-Ala-Gly-Ala-Ser-Arg-Leu-Leu-Leu-Leu-Thr-Gly-Glu-Ile-Asp-Leu-Pro-OH |
| H-1501 | Head activator | C54H84N12O14 | 1125.33 | 79943-68-3 | Pyr-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe-OH |
| H-1502 | Head activator (7-11) | C32H54N6O6 | 618.82 | 103404-59-7 | H-Lys-Val-Ile-Leu-Phe-OH Acetate salt |
| H-1503 | Pedibin Precursor (hydra) | C228H369N61O86S | 5372.86 | H-Met-Glu-Ser-Glu-His-Glu-Val-Ser-Thr-Pro-Val-Ser-Ala-Glu-Glu-Leu-Lys-Ala-Glu-Ile-Ala-Val-Leu-Gln-Glu-Lys-Leu-Ala-Ala-Gly-Glu-Asp-Val-Ser-His-Glu-Leu-Glu-Glu-Lys-Glu-Lys-Ala-Leu-Ala-Asn-His-Ser-Glu-OH | |
| H-1601 | Hydrin 1, (Arg8,Gly10,Lys11,Arg12)-Vasotocin | C57H93N21O16S2 | 1392.63 | 122842-47-1 | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys-Arg-OH (Disulfide bond) |
| H-1602 | Hydrin 1', (Arg8,Gly10,Lys11)-Vasotocin | C51H81N17O15S2 | 1236.44 | 148440-73-7 | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-Lys-OH (Disulfide bond) |
| H-1603 | Hydrin 2 (Arg8,Gly10)-Vasotocin |
C45H69N15O14S2 | 1108.27 | 122842-55-1 | H-Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Arg-Gly-Gly-OH (Disulfide bond) |
| H-1701 | Hylambatin | C63H90N16O19S2 | 1439.64 | 80890-46-6 | H-Asp-Pro-Pro-Asp-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 |
| H-1702 | Entero-Hylambatin | C63H91N17O18S2 | 1438.65 | 198541-90-1 | H-Asp-Pro-Pro-Asn-Pro-Asp-Arg-Phe-Tyr-Gly-Met-Met-NH2 |
| I-0101 | C23H32N5O12P | 601.51 | 290810-63-8 | H-Asn-Pro-Glu-Tyr(PO3H2)-OH | |
| I-0102 | IGF-I Analog | C55H88N14O15S2 | 1249.52 | 147819-32-7 | H-Cys-Tyr-Ala-Ala-Pro-Leu-Lys-Pro-Ala-Lys-Ser-Cys-OH (Disulfide bond) |
